15.15
Modelli farmacodinamici: modello Link e modello farmacodinamico di sistema
Il modello Link è un approccio farmacocinetico–farmacodinamico (PK–PD) fondamentale per tenere conto delle risposte ritardate al farmaco quando l’effe…
Il modello di collegamento tiene conto della risposta ritardata al farmaco quando l'effetto non è allineato con la concentrazione plasmatica di picco.
Introduce un compartimento effetto, con una concentrazione indicata come Ce, legata alla concentrazione plasmica, Cp, tramite una costante di velocità ke0, ed è modellata utilizzando l'equazione Emax .
La velocità di variazione della concentrazione di farmaco nel sito d'effetto viene calcolata utilizzando la seguente equazione.
Un grande valore di ke0 indica un rapido equilibrio tra il compartimento dell'effetto e il plasma, mentre un ke0 più piccolo significa un equilibrio più lento e un effetto ritardato rispetto a Cp.
Di conseguenza, tracciare la risposta in funzione della concentrazione plasmatica forma un circuito di isteresi in senso antiorario. D'altra parte, farmaci liposolubili come fentanyl e cocaina possono mostrare un'isteresi in senso orario.
I modelli farmacodinamici dei sistemi integrano processi biologici utilizzando equazioni che incorporano omeostasi e meccanismi di feedback. Valutano come un cambiamento in un processo influisce sull'intero sistema fisiologico.
View the full transcript and gain access to JoVE Core videos
Q1: What is an effect compartment and how does it relate to the link model?
The effect compartment is a theoretical compartment where drug concentration (Ce) is kinetically linked to plasma concentration (Cp) through a rate constant ke0. This linkage allows the link model to account for delayed drug responses when the observed effect does not immediately correlate with peak plasma concentration. The effect compartment mathematically bridges the time gap between drug presence in plasma and its actual pharmacological effect at the receptor site.
Q2: How does the ke0 rate constant affect drug response timing?
The ke0 rate constant determines the speed of equilibration between the effect compartment and plasma. A large ke0 value indicates rapid equilibration, aligning the drug effect closely with the plasma concentration profile. Conversely, a smaller ke0 means slower equilibration, causing the observed drug effect to lag significantly behind the plasma concentration curve, resulting in a delayed pharmacological response.
Q3: What do counterclockwise and clockwise hysteresis loops represent in concentration-response plots?
Counterclockwise hysteresis loops, typical of most drugs, indicate a delayed effect relative to plasma concentration due to slower equilibration at the effect site. Clockwise hysteresis, observed in lipid-soluble drugs like fentanyl and cocaine, reflects tolerance or receptor desensitization mechanisms over time. These graphical patterns reveal the temporal dynamics of drug-receptor interactions and help distinguish between different pharmacological mechanisms.
Q4: How do systems pharmacodynamic models differ from the link model?
Systems pharmacodynamic models extend beyond single-compartment link dynamics by integrating multiple biological processes using equations that incorporate homeostasis and feedback mechanisms. While the link model addresses delayed drug responses through an effect compartment, systems models assess how changes in one physiological process impact the entire system. This comprehensive approach enables predictions of systemic responses to pharmacological interventions.
Q5: Why are systems pharmacodynamic models important for drug development?
Systems pharmacodynamic models are robust tools for understanding how alterations in one biological pathway influence the entire physiological system. They enable researchers to predict complex systemic responses to pharmacological interventions, making them indispensable for optimizing drug development and therapeutic strategies. This systems-level perspective helps identify potential drug interactions and off-target effects before clinical trials.
Q6: What mathematical equation is used to model drug concentration at the effect site?
The rate of change in drug concentration at the effect site is calculated using a first-order rate equation that incorporates the ke0 rate constant and the difference between plasma and effect compartment concentrations. This equation, combined with the Emax model, allows pharmacologists to predict how drug concentration evolves at the receptor site over time, accounting for the kinetic linkage between plasma and effect compartments.
Q7: How does the link model account for delayed drug responses compared to direct effect models?
The link model introduces an effect compartment with its own concentration dynamics, allowing it to capture the time delay between peak plasma concentration and maximum drug effect. Direct effect models assume immediate correlation between plasma concentration and response, missing this temporal lag. By incorporating the ke0-mediated equilibration process, the link model provides more accurate predictions of drug effects, particularly for drugs with delayed onset of action.